Export 943 results:
Author Title [ Type
Filters: First Letter Of Last Name is P [Clear All Filters]
“2009 Update from the Collaborative Islet Transplant Registry”, Paris France: , 2009.
, “Association for Accreditation of Human Subject Research Protection Programs (AAHRPP)”, Masur Auditorium Natcher Conference Center, NIH Campus: , 2009.
, “Association for Accreditation of Human Subject Research Protection Programs (AAHRPP)”, Masur Auditorium Natcher Conference Center, NIH Campus: , 2009.
, , “45th Annual Meeting of the American Society of Clinical Oncology (ASCO)”, presented at the 2009, Orlando FL, 2009.
, “Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
, “BK virus is not a significant cause of graft loss in HIV+ kidney recipients (oral presentation)”, presented at the 2011, Philadelphia, PA, 2011.
, “BOLD-100-001 (TRIO039): A phase Ib Dose-escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Gastrointestinal Solid Tumors”, in ASCO Annual Meeting, 2021.
, “Characteristics of CD34-Enriched Products Processed at Multiple Centers Using the CliniMACS System - BMT CTN 0303 (Abstract).”, in 16th Annual ISCT (International Society for Cellular Therapy) Meeting, Philadelphia, 2010.
, “Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers”, in HIVR4P (HIV Research for Prevention), Cape Town, South Africa, 2014.
, “Cognitive Function at Age 6 Years in Children Exposed In Utero to Antiepileptic Drug”, in 65th American Epilepsy Society's Annual Meeting, Baltimore, MD, 2011.
, “Cognitive Function at Age 6 Years in Children Exposed In Utero to Antiepileptic Drug”, in 65th American Epilepsy Society's Annual Meeting, Baltimore, MD, 2011.
, “Comparative Effectiveness Analysis of CD34+ Selected, T-Cell Depleted (TCD) HLA-Matched Sibling Grafts on Allogeneic Hematopoietic Cell Transplantation for Patients with Acute Myeloid Leukemia (AML) in Complete Remiss (Poster).”, in BMT Tandem Meeting, Orlando, FL, 2010.
, “A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials”, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
“Cure Sickle Cell Initiative Standardized Data Forms for Genetic Therapy Studies”, in American Society of Gene and Cell Therapy, Virtual, 2021.
, “Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults”, presented at the 2011, Honolulu, HI, 2011, vol. 17 No 2 Su, pp. S 185 - 186.
, “Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults”, presented at the 2011, Honolulu, HI, 2011, vol. 17 No 2 Su, pp. S 185 - 186.
, “Effects of Breastfeeding in Women Taking Antiepileptic Drugs on Their Children’s Cognitive Outcomes”, in American Academy of Neurology Annual Meeting, Chicago, IL, 2008.
, “Effects of Breastfeeding in Women Taking Antiepileptic Drugs on Their Children’s Cognitive Outcomes”, in American Academy of Neurology Annual Meeting, Chicago, IL, 2008.
, “Experience in a Public Cord Blood Bank Using a Segment-Based Aldehyde Dehydrogenase Assay as a Biomarker for Umbilical Cord Blood Potency”, in American Society for Blood and Marrow Transplantation Annual Meeting, Grapevine, TX, 2014.
, “Factors Influencing Adherence Behavior for Daily and Intermittent Regimens of Pre-Exposure Prophylaxis (PrEP) Among Men Who Have Sex With Men (MSM) in Kenya”, in Adherence 2013, Miami, FL, 2013.
, “GCP Compliance Supporting Efficacy/Effectiveness Studies”, presented at the 22/06/2011, Bethesda, MD, 2011.
, “Grade III - IV Acute GvHD and Treatment-Related Mortality Are Reduced Among Recipients of Larger Numbers of Donor Naïve CD8+ T-cells and Plasmacytoid Dendritic Cell Precursors in Allogeneic BM Grafts from Unrelated Donors: Results from BMT CTN 0201”, in 38th Annual EBMT (European Group for Blood and Marrow Transplantation), Geneva, Switzerland, 2012.
, “GVHD Biomarkers Measured During Treatment Independently Predict Response to Therapy and Survival: A Blood and Marrow Transplant Clinical Trials Network Study (Abstract)”, presented at the 2011, Paris, France, 2011.
, “Incorporating Web-based Training Tools and Technology in Clinical Trials Training”, in Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
,